Dear Colleague, I am pleased to invite you to the one-day event Impact of the New European Pharmacovigilance Legislation taking place October 15, 2012 in London at the British Medical Association House. Seating is limited - Register early to ensure that you and your colleagues can attend this important and informative event. Seating is limited - Register now! Our featured speakers include experts from regulatory and industry: Xavier Kurz, PhV and RM, European Medicines Agency John Parkinson, Head of CPRD Claire Tilstone, Editor, The Medicines and Health Products Regulatory Agency Paul Dolin, Director, Takeda Pharmaceuticals Sinem Ezgi Gulmez, Associate Professor of Pharmacology, Pharmacoepidemiology and Drug Safety, University Bordeaux Segalen Francois Simondon, Epidemiology Executive Director, Sanofi Pasteur MSD Macey Murray, Teaching and Research Fellow, University College London, Centre for Paediatric Pharmacy Research Saad A.W. Shakir, MD, Director, Drug Safety Research Unit And more… Held approximately 100 days after the 2 July effective date, this conference is designed to promote discussion on how implementation is proceeding. Challenges, concerns, and successes will be presented from an array of industry and regulatory experts. If you are in the planning phase or well into the implementation of this new legislation, please join us to add to the robust discussion. Challenges, concerns and successes will be presented from an array of academic, industry and regulatory experts. I look forward to seeing you on October 15 in London at the BMA House on Tavistock Square. Seating is limited –register early to reserve your seat! Sincerely, William C Maier, MPH, PhD Scientific advisor MAPI Research Trust